Receptor tyrosine kinase-like orphan receptor 1 inhibitor strictinin exhibits anti-cancer properties against highly aggressive androgen-independent prostate cancer
Article in Exploration of Targeted Anti-tumor Therapy (December 2023)
The most recent citing publications are shown below. View all 20 publications that cite this research output on Dimensions.
Identification and validation of microtubule depolymerizing agent, CYT997, as a potential drug candidate for hepatocellular carcinoma
Article in Liver International (October 2023)
Evaluation of the Efficacy of Saracatinib-Loaded Nanoparticles in Lymphatic Metastases of HNSCC with the Aid of Bioluminescence Imaging
Book chapter (July 2022)